CRIS Current Research Information System

ISIDORI, ALESSANDRO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.303
AS - Asia 1.904
EU - Europa 1.449
SA - Sud America 98
AF - Africa 96
Continente sconosciuto - Info sul continente non disponibili 16
OC - Oceania 4
Totale 5.870
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.269
SG - Singapore 527
VN - Vietnam 487
CN - Cina 458
GB - Regno Unito 297
SE - Svezia 244
IT - Italia 197
DE - Germania 195
HK - Hong Kong 119
FR - Francia 98
IN - India 94
BR - Brasile 70
UA - Ucraina 68
RU - Federazione Russa 66
IE - Irlanda 62
NL - Olanda 55
FI - Finlandia 38
JP - Giappone 37
TG - Togo 36
KR - Corea 29
ZA - Sudafrica 29
BG - Bulgaria 27
BD - Bangladesh 25
CH - Svizzera 25
CA - Canada 20
JO - Giordania 20
EE - Estonia 19
ID - Indonesia 19
CI - Costa d'Avorio 17
BE - Belgio 16
EU - Europa 16
PH - Filippine 12
TR - Turchia 12
TH - Thailandia 11
GR - Grecia 9
MX - Messico 9
AR - Argentina 8
IR - Iran 8
TW - Taiwan 8
IQ - Iraq 7
SA - Arabia Saudita 7
CO - Colombia 6
ES - Italia 6
LB - Libano 6
PL - Polonia 6
SC - Seychelles 6
UZ - Uzbekistan 5
AU - Australia 4
EC - Ecuador 4
PY - Paraguay 4
RO - Romania 4
AT - Austria 3
HR - Croazia 3
MY - Malesia 3
PE - Perù 3
PK - Pakistan 3
BO - Bolivia 2
CZ - Repubblica Ceca 2
MA - Marocco 2
OM - Oman 2
SV - El Salvador 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
ET - Etiopia 1
GD - Grenada 1
GI - Gibilterra 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
LT - Lituania 1
LU - Lussemburgo 1
MG - Madagascar 1
MK - Macedonia 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
Totale 5.870
Salva come PNG Salva come JPEG
Città #
Singapore 373
Ashburn 289
Southend 251
Chandler 190
Fairfield 179
Dong Ket 128
San Jose 127
Woodbridge 119
Hong Kong 109
Houston 104
Wilmington 102
Seattle 99
Ho Chi Minh City 96
Ann Arbor 88
Hanoi 87
Beijing 79
Santa Clara 78
Cambridge 76
Hefei 73
Princeton 63
Dublin 60
New York 52
Jacksonville 46
Los Angeles 44
Boardman 42
Lomé 36
Tokyo 31
Lauterbourg 29
Helsinki 27
Nanjing 27
Sofia 27
Westminster 27
Berlin 25
Bologna 25
Seoul 24
Bremen 23
Bern 22
Hyderabad 22
Frankfurt am Main 21
Amman 20
Milan 18
Padova 18
Abidjan 17
Munich 16
Turin 16
Brussels 15
Da Nang 15
San Diego 15
Dallas 14
Haiphong 14
Buffalo 13
Jinan 13
Council Bluffs 12
Norwalk 12
São Paulo 11
Guangzhou 10
Zhengzhou 10
Chicago 9
Orem 9
Redmond 9
Redondo Beach 9
Saint Petersburg 9
Changsha 8
Jakarta 8
Jiaxing 8
Mülheim 8
Tianjin 8
Bengaluru 7
Olalla 7
Rome 7
Salsomaggiore Terme 7
Shenyang 7
Toronto 7
Turku 7
Yubileyny 7
Hebei 6
London 6
Mexico City 6
Nanchang 6
Phoenix 6
Verona 6
Bangkok 5
Changchun 5
Des Moines 5
Falls Church 5
Johannesburg 5
Mahé 5
Montreal 5
San Francisco 5
Tashkent 5
Amsterdam 4
Biên Hòa 4
Brooklyn 4
Chengdu 4
Chennai 4
Chongqing 4
Falkenstein 4
Foshan 4
Hangzhou 4
Hải Dương 4
Totale 3.841
Salva come PNG Salva come JPEG
Nome #
Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. 271
Acute myeloid leukemia cells constitutively express the immunoregulatory enzyme indoleamine 2,3-dioxygenase. 253
Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients. 232
NUCLEOFECTION IS AN EFFICIENT NON-VIRAL TRANSFECTION TECHNIQUE FOR HUMAN BONE MARROW-DERIVED MESENCHYMAL STEM CELLS. 226
Durability of spleen response affects the outcome of ruxolitinib-treated patients with myelofibrosis: Results from a multicentre study on 284 patients 226
Impact of comorbidities and body mass index in patients with myelofibrosis treated with ruxolitinib 214
Genetic profiling in acute myeloid leukemia: a path to predicting treatment outcome 214
Successful transfer of alloreactive haploidentical KIR ligand-mismatched natural killer cells after infusion in elderly high risk acute myeloid leukemia patients. 210
No preferential sensitivity of t(8;21) acute myeloid leukemias to cytosine arabinoside in vitro: is intensity of therapy or high dose Ara-C crucial for response? 208
Gemtuzumab ozogamicin for relapsed and refractory acute myeloid leukemia and myeloid sarcomas 208
Efficacy and safety of ruxolitinib in intermediate-1 IPSS risk myelofibrosis patients: Results from an independent study 206
Association of 3q21q26 syndrome with different RPN1/EVI1 fusion transcripts 192
Low-dose lenalidomide plus cytarabine in very elderly, unfit acute myeloid leukemia patients: Final result of a phase II study 191
Chemotherapy-Induced Tumor Cell Death at the Crossroads Between Immunogenicity and Immunotolerance: Focus on Acute Myeloid Leukemia 190
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patients 188
Stem cell mobilization and collection in patients with liver cirrhosis. 186
Dendritic cell differentiation. 183
Modulation of tryptophan catabolism by human leukemic cells results in the conversion of CD25- into CD25+ T regulatory cells. 182
Ruxolitinib in elderly patients with myelofibrosis: impact of age and genotype. A multicentre study on 291 elderly patients 179
Interleukin-12 production by leukemia-derived dendritic cells counteracts the inhibitory effect of leukemic microenvironment on T cells. 175
Autologous stem cell transplantation for acute myeloid leukemia patients in first complete remission: a 10-year follow-up study of 118 patients. 167
Life after ruxolitinib: Reasons for discontinuation, impact of disease phase, and outcomes in 218 patients with myelofibrosis 159
Gene expression profile predicts response to the combination of tosedostat and low-dose cytarabine in elderly AML 157
Impact of 2016 WHO diagnosis of early and overt primary myelofibrosis on presentation and outcome of 232 patients treated with ruxolitinib. 155
Impact of calreticulin mutations on treatment and survival outcomes in myelofibrosis during ruxolitinib therapy 149
Consolidation therapy for adult acute myeloid leukemia: A systematic analysis according to evidence based medicine 142
Metabolic Switch and Cytotoxic Effect of Metformin on Burkitt Lymphoma 141
Persistent immune stimulation exacerbates genetically driven myeloproliferative disorders via stromal remodeling 138
The Yin and Yang of the Bone Marrow Microenvironment: Pros and Cons of Mesenchymal Stromal Cells in Acute Myeloid Leukemia 138
Ponatinib as second-line treatment in chronic phase chronic myeloid leukemia patients in real-life practice 127
Molecular monitoring of acute myeloid leukemia associated with inv(16): Threshold of CBFβ/MYH11 transcript copy number above which relapse occurs and below which continuous complete remission is likely (multiple letters) [8] 119
Erratum: Phase II study of a single pegfilgrastim injection as an adjunct to chemotherapy to mobilize stem cells into the peripheral blood of pretreated lymphoma patients (Haematologica (2005) 90, (225-231). 82
Two more inv(16) acute myeloid leukemia cases with infrequent CBFβ-MYH11 fusion transcript: Clinical and molecular findings [4] 70
The role of menin inhibitors in acute myeloid leukemia 59
Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351 33
Clinical benefit and predictors of response to momelotinib after ruxolitinib failure: A cooperative real‐world study 8
Totale 5.978
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.788
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.788
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021139 0 0 0 0 0 0 0 0 0 0 0 139
2021/2022658 55 26 37 75 51 39 22 37 34 62 130 90
2022/2023791 89 110 42 107 40 65 20 50 129 16 63 60
2023/2024261 16 42 18 32 14 79 7 12 2 16 8 15
2024/2025720 39 73 46 74 116 30 52 9 28 69 25 159
2025/20261.949 146 144 144 169 240 104 172 94 435 162 77 62
Totale 5.978